{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:41:44Z","timestamp":1782232904348,"version":"3.54.5"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.yexmp.2024.104904","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T10:38:29Z","timestamp":1716633509000},"page":"104904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies \u2013 Spotlight on prostate and colorectal cancer"],"prefix":"10.1016","volume":"137","author":[{"given":"Guodong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Zian Vi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Kai","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinren","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanchal","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Enikeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Efetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingze","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0005","first-page":"7","article-title":"What we need to know about liposomes as drug nanocarriers: an updated review","volume":"13","author":"Abbasi","year":"2023","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.bmb.a070956","article-title":"Chemical radiosensitization of hypoxic cells","volume":"29","author":"Adams","year":"1973","journal-title":"Br. Med. Bull."},{"issue":"24","key":"10.1016\/j.yexmp.2024.104904_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/nano12244494","article-title":"Nanoparticles in drug delivery: from history to therapeutic applications","volume":"12","author":"Afzal","year":"2022","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2024.104904_bb0025","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1039\/D0BM01672A","article-title":"Machine learning integrated omics for nanomaterials risk and safety assessment","volume":"9","author":"Ahmad","year":"2021","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","article-title":"Diagnosis and staging of bladder cancer","volume":"35","author":"Ahmadi","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"10071","key":"10.1016\/j.yexmp.2024.104904_bb0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13139-023-00812-7","article-title":"Synchronous colorectal and prostate Cancer: dual PET\/CT approach for detecting and distinguishing metastatic patterns","volume":"57","author":"Al-Ibraheem","year":"2023","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"23","key":"10.1016\/j.yexmp.2024.104904_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235672","article-title":"Recent Progress in bioconjugation strategies for liposome-mediated drug delivery","volume":"25","author":"Almeida","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/wnan.1353","article-title":"Combinatorial nanomedicines for colon cancer therapy","volume":"8","author":"Anitha","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0055","first-page":"1","article-title":"Dendrimer\u2212silver complexes and nanocomposites as antimicrobial agents","author":"Balogh","year":"2000","journal-title":"Nano Letters - NANO LETT."},{"issue":"7229","key":"10.1016\/j.yexmp.2024.104904_bb0060","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.yexmp.2024.104904_bb0070","first-page":"1","article-title":"Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers","volume":"4","author":"Bharali","year":"2009","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/TUB-200069","article-title":"CA125: a superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242","volume":"43","author":"Bj\u00f6rkman","year":"2021","journal-title":"Tumour Biol: J. Intern. Soc. Oncodevelop. Biol. Med."},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/b309043b","article-title":"Dendrimers in drug research","volume":"33","author":"Boas","year":"2004","journal-title":"Chem. Soc. Rev."},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103237","article-title":"Application of dendrimers in anticancer diagnostics and therapy","volume":"27","author":"Bober","year":"2022","journal-title":"Molecule"},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092102","article-title":"Nano-enhanced cancer immunotherapy: immunology encounters nanotechnology","volume":"9","author":"Bockamp","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bpg.2016.07.002","article-title":"The rationale of combined radiotherapy and chemotherapy - joint action of Castor and Pollux","volume":"30","author":"Brunner","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s13402-022-00725-1","article-title":"Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response","volume":"45","author":"Bu","year":"2022","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"14","key":"10.1016\/j.yexmp.2024.104904_bb0110","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","author":"Cedermark","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0115","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","article-title":"Revisiting immunotherapy: a focus on prostate cancer","volume":"80","author":"Cha","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"37","key":"10.1016\/j.yexmp.2024.104904_bb0125","doi-asserted-by":"crossref","first-page":"62742","DOI":"10.18632\/oncotarget.18409","article-title":"Improving radiotherapy in cancer treatment: promises and challenges","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexmp.2024.104904_bb0130","first-page":"3403","article-title":"Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K\/mTOR dual inhibitor BEZ-235 through apoptotic pathways","volume":"9","author":"Chen","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"17","key":"10.1016\/j.yexmp.2024.104904_bb0135","article-title":"Applications and limitations of dendrimers in biomedicine","volume":"25","author":"Chis","year":"2020","journal-title":"Molecules (Basel, Switzerl.)"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0140","first-page":"142","article-title":"Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy","volume":"10","author":"Choksi","year":"2022","journal-title":"Am. J. Clin. Exper. Urol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0145","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/IJN.S375229","article-title":"Current advances in chitosan nanoparticles based oral drug delivery for colorectal cancer treatment","volume":"17","author":"Choukaife","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yexmp.2024.104904_bb0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.actbio.2019.07.003","article-title":"DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen","volume":"96","author":"Cole","year":"2019","journal-title":"Acta Biomater."},{"issue":"9290","key":"10.1016\/j.yexmp.2024.104904_bb0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(01)06409-1","article-title":"Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030869","article-title":"Cationic polymer nanoparticles-mediated delivery of miR-124 impairs tumorigenicity of prostate cancer cells","volume":"21","author":"Conte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0165","article-title":"The nanosystems involved in treating lung cancer","volume":"11","author":"Crintea","year":"2021","journal-title":"Life (Basel)."},{"key":"10.1016\/j.yexmp.2024.104904_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15051406","article-title":"Dendrimers: advancements and potential applications in cancer diagnosis and treatment-an overview","volume":"15","author":"Crintea","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.yexmp.2024.104904_bb0175","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","article-title":"Prevention and early detection of prostate cancer","volume":"15","author":"Cuzick","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0180","first-page":"9","article-title":"PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics","author":"Dai","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.yexmp.2024.104904_bb0185","article-title":"Consensus delineation guidelines for pelvic lymph node radiation therapy of prostate cancer: on behalf of the francophone Group of Urological Radiation Therapy (GFRU)","author":"De Hertogh","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2246","article-title":"Trends in incidence of metastatic prostate cancer in the US","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0195","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010104","article-title":"Nanoformulated Zoledronic acid boosts the V\u03b42 T cell immunotherapeutic potential in colorectal cancer","volume":"12","author":"Di Mascolo","year":"2019","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.yexmp.2024.104904_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147726","article-title":"Carbon-based nanomaterials","volume":"22","author":"D\u00edez-Pascual","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2024.104904_bb0210","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.msec.2017.03.130","article-title":"A review of drug release mechanisms from nanocarrier systems","volume":"76","author":"Ding","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb0215","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019Souza","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00280-016-3193-5","article-title":"Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial","volume":"79","author":"Ducreux","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as biocompatible and smart delivery systems - the current state","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104904_bb0230","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00384-010-0903-z","article-title":"Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin","volume":"25","author":"Fan","year":"2010","journal-title":"Int. J. Color. Dis."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0305-7372(76)80012-6","article-title":"Radiosensitizers of hypoxic cells in solid tumors","volume":"3","author":"Fowler","year":"1976","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.yexmp.2024.104904_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.06.005","article-title":"PAMAM dendrimer - cell membrane interactions","volume":"257","author":"Fox","year":"2018","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","article-title":"Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy","volume":"12","author":"Fu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.yexmp.2024.104904_bb0260","article-title":"Quantum dots: prospectives, toxicity, advances and applications","volume":"61","author":"Gidwani","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5\u20136","key":"10.1016\/j.yexmp.2024.104904_bb0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/02841860310012301","article-title":"A systematic overview of radiation therapy effects in rectal cancer","volume":"42","author":"Glimelius","year":"2003","journal-title":"Acta Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0270","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1535-7163.MCT-16-0114","article-title":"LGR5-targeted antibody-drug conjugate eradicates gastrointestinal tumors and prevents recurrence","volume":"15","author":"Gong","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexmp.2024.104904_bb0275","first-page":"4","article-title":"Engineering gold-based radiosensitizers for cancer radiotherapy","author":"Goswami","year":"2017","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.yexmp.2024.104904_bb0280","first-page":"102","article-title":"Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy","volume":"26","author":"Gu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.yexmp.2024.104904_bb0285","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fonc.2020.00586","article-title":"FOLFOX chemotherapy ameliorates CD8 T lymphocyte exhaustion and enhances checkpoint blockade efficacy in colorectal cancer","volume":"10","author":"Guan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0295","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/acsnano.0c01676","article-title":"Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.yexmp.2024.104904_bb0305","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1021\/acsami.1c00852","article-title":"Sequential release of pooled siRNAs and paclitaxel by aptamer-functionalized Shell-Core nanoparticles to overcome paclitaxel resistance of prostate cancer","volume":"13","author":"Guo","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"23","key":"10.1016\/j.yexmp.2024.104904_bb0310","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.2217\/nnm-2017-0236","article-title":"Current prospects and challenges of nanomedicine delivery in prostate cancer therapy","volume":"12","author":"Gupta","year":"2017","journal-title":"Nanomedicine (London)"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0315","first-page":"97","article-title":"Novel aldehyde-terminated dendrimers; synthesis and cytotoxicity assay","volume":"2","author":"Hamidi","year":"2012","journal-title":"Bioimpacts"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clinre.2014.07.008","article-title":"LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis","volume":"39","author":"Han","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.yexmp.2024.104904_bb0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/0284186X.2010.576115","article-title":"Curative radiation therapy in prostate cancer","volume":"50","author":"Harmenberg","year":"2011","journal-title":"Acta Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11072000","article-title":"Nab-paclitaxel in the treatment of gastrointestinal cancers-improvements in clinical efficacy and safety","volume":"11","author":"Hassan","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0335","doi-asserted-by":"crossref","first-page":"81","DOI":"10.29252\/ibj.24.2.81","article-title":"Engineered Jurkat cells for targeting prostate-specific membrane antigen on prostate cancer cells by nanobody-based chimeric antigen receptor","volume":"24","author":"Hassani","year":"2020","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.yexmp.2024.104904_bb0340","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.2147\/IJN.S420803","article-title":"A pegylated liposome loaded with Raddeanin a for prostate cancer therapy","volume":"18","author":"He","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19147","article-title":"Chimeric antigen receptor-modified T cells therapy in prostate cancer: a comprehensive review on the current state and prospects","volume":"9","author":"He","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.yexmp.2024.104904_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1189370","article-title":"Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on the current status and perspectives","volume":"13","author":"He","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0355","first-page":"14","article-title":"Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy","author":"He","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0360","article-title":"Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline","volume":"367","author":"Helsingen","year":"2019","journal-title":"Bmj"},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071732","article-title":"Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.yexmp.2024.104904_bb0370","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00384-013-1721-x","article-title":"Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer","volume":"28","author":"Hsu","year":"2013","journal-title":"Int. J. Color. Dis."},{"issue":"38","key":"10.1016\/j.yexmp.2024.104904_bb0375","doi-asserted-by":"crossref","first-page":"42511","DOI":"10.1021\/acsami.0c11636","article-title":"Cell membrane-inspired polymeric vesicles for combined Photothermal and photodynamic prostate cancer therapy","volume":"12","author":"Hu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071868","article-title":"Gold nanoparticles: construction for drug delivery and application in cancer immunotherapy","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0385","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.molpharmaceut.5b00051","article-title":"Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0390","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0022-5347(17)36939-2","article-title":"Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography","volume":"148","author":"Inaba","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0395","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2147\/IJN.S127683","article-title":"A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine","volume":"12","author":"Jahangirian","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.yexmp.2024.104904_bb0400","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","article-title":"Dendrimer toxicity: let\u2019s meet the challenge","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yexmp.2024.104904_bb0405","article-title":"Regulation of hedgehog signaling by miRNAs and nanoformulations: a possible therapeutic solution for colorectal Cancer","volume":"10","author":"Javed","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110224","article-title":"A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer","volume":"107","author":"Jiang","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12951-020-00629-y","article-title":"Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges","volume":"18","author":"Jin","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118731","article-title":"Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines","volume":"572","author":"Jin","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"6382","key":"10.1016\/j.yexmp.2024.104904_bb0425","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.yexmp.2024.104904_bb0430","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pros.23214","article-title":"Phase I trial of anti-PSMA designer CAR-T cells in prostate cancer: possible role for interacting interleukin 2-T cell pharmacodynamics as a determinant of clinical response","volume":"76","author":"Junghans","year":"2016","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0435","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexmp.2024.104904_bb0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2017.09.039","article-title":"Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder","volume":"111","author":"Kaldybekov","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0445","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.nano.2018.01.008","article-title":"Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles ((99m)Tc-Res-AuNP) in colon cancer tissue","volume":"14","author":"Kamal","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb0450","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.yexmp.2024.104904_bb0455","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1021\/acsomega.2c07840","article-title":"Smart nanomaterials in cancer theranostics: challenges and opportunities","volume":"8","author":"Kashyap","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0460","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12951-022-01364-2","article-title":"Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms","volume":"20","author":"Kaushik","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96224-8","article-title":"Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy","volume":"11","author":"Khoobchandani","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0470","article-title":"Recent metal nanotheranostics for cancer diagnosis and therapy: a review","volume":"13","author":"Khorasani","year":"2023","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010203","article-title":"Selective targeting of cancer stem cells (CSCs) based on photodynamic therapy (PDT) penetration depth inhibits colon polyp formation in mice","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers"},{"issue":"13\u201314","key":"10.1016\/j.yexmp.2024.104904_bb0480","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.addr.2013.09.001","article-title":"Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities","volume":"65","author":"Kirtane","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"99","key":"10.1016\/j.yexmp.2024.104904_bb0485","doi-asserted-by":"crossref","first-page":"14611","DOI":"10.1039\/D3CC03182A","article-title":"Dendrimersomes: biomedical applications","volume":"59","author":"Klajnert-Maculewicz","year":"2023","journal-title":"Chem. Commun. (Camb.)"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0490","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2006.03.001","article-title":"In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors","volume":"112","author":"Koziara","year":"2006","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0495","first-page":"330","article-title":"Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer","volume":"2","author":"Kwatra","year":"2013","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0500","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6604483","article-title":"Tumour-targeted nanomedicines: principles and practice","volume":"99","author":"Lammers","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0505","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1021\/acs.molpharmaceut.9b00181","article-title":"Evaluation of PSMA-targeted PAMAM dendrimer nanoparticles in a murine model of prostate Cancer","volume":"16","author":"Lesniak","year":"2019","journal-title":"Mol. Pharm."},{"issue":"Pt 2","key":"10.1016\/j.yexmp.2024.104904_bb0510","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.semcancer.2022.05.014","article-title":"Nanomedicine for urologic cancers: diagnosis and management","volume":"86","author":"Li","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0515","first-page":"27","article-title":"Preclinical evaluation of a clinical prototype transrectal diffuse optical tomography system for monitoring photothermal therapy of focal prostate cancer","author":"Li","year":"2022","journal-title":"J. Biomed. Opt."},{"issue":"15","key":"10.1016\/j.yexmp.2024.104904_bb0520","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.7150\/thno.87854","article-title":"Stimuli-activatable nanomedicine meets cancer theranostics","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0525","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1021\/acs.biomac.8b00734","article-title":"Tumor-pH-sensitive PLLA-based microsphere with acid cleavable acetal bonds on the backbone for efficient localized chemotherapy","volume":"19","author":"Li","year":"2018","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0530","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12951-023-01943-x","article-title":"Oncogene-targeting nanoprobes for early imaging detection of tumor","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0535","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/1568009616666161216095308","article-title":"Virus, oncolytic virus and human prostate cancer","volume":"17","author":"Liu","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexmp.2024.104904_bb0540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/pharmaceutics13111757","article-title":"Advances of nanomedicine in radiotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexmp.2024.104904_bb0545","doi-asserted-by":"crossref","DOI":"10.5936\/csbj.201302011","article-title":"Current progress in structure-based rational drug design marks a new mindset in drug discovery","volume":"5","author":"Lounnas","year":"2013","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0550","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.juro.2012.01.061","article-title":"Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States","volume":"187","author":"Lowrance","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0555","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5762431","article-title":"Recent Progress on nanostructures for drug delivery applications","volume":"2016","author":"Lu","year":"2016","journal-title":"J. Nanomater."},{"issue":"35","key":"10.1016\/j.yexmp.2024.104904_bb0560","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1039\/C9SC02290B","article-title":"Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?","volume":"10","author":"Luo","year":"2019","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0565","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1021\/acs.nanolett.0c02487","article-title":"Targeted Radiosensitizers for MR-guided radiation therapy of prostate cancer","volume":"20","author":"Luo","year":"2020","journal-title":"Nano Lett."},{"issue":"13","key":"10.1016\/j.yexmp.2024.104904_bb0570","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1021\/acsami.1c23780","article-title":"Targeted chemoradiotherapy of prostate cancer using gold nanoclusters with protease activatable monomethyl Auristatin E","volume":"14","author":"Luo","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0575","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.apsb.2021.05.003","article-title":"GSH-sensitive polymeric prodrug: synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0580","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40169-018-0185-6","article-title":"Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs","volume":"7","author":"Maeda","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexmp.2024.104904_bb0585","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biopha.2018.11.145","article-title":"Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer","volume":"110","author":"Mahira","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0590","article-title":"Mesoporous silica nanoparticles for","volume":"30","author":"Manzano","year":"2020","journal-title":"Drug Deliv."},{"issue":"14","key":"10.1016\/j.yexmp.2024.104904_bb0595","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.7150\/thno.72509","article-title":"Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy","volume":"12","author":"Mao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.yexmp.2024.104904_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102477","article-title":"Targeting prostate cancer with Clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity","volume":"40","author":"Martin","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0605","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R","article-title":"The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study","volume":"92","author":"Martling","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2024.104904_bb0610","first-page":"142","article-title":"Biogenic silica nanoparticles loaded with neem bark extract as green, slow-release biocide","author":"Mattos","year":"2016","journal-title":"J. Clean. Prod."},{"key":"10.1016\/j.yexmp.2024.104904_bb0615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2017.07.025","article-title":"Controlled release for crop and wood protection: recent progress toward sustainable and safe nanostructured biocidal systems","volume":"262","author":"Mattos","year":"2017","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.yexmp.2024.104904_bb0620","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986711795933731","article-title":"Strategies in the rational drug design","volume":"18","author":"Mavromoustakos","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0625","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1166\/jbn.2014.1841","article-title":"Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells","volume":"10","author":"Maya","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0630","article-title":"PSMA-targeted nanotheranostics for imaging and radiotherapy of prostate cancer","volume":"16","author":"Meher","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerl.)"},{"key":"10.1016\/j.yexmp.2024.104904_bb0635","first-page":"3637","article-title":"Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy","volume":"7","author":"Miele","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0640","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40089-014-0094-7","article-title":"Nanomedicine and drug delivery: a mini review","volume":"4","author":"Mirza","year":"2014","journal-title":"Int. Nano Lett."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0645","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0650","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14712598.2022.2027904","article-title":"Prostate cancer immunotherapy","volume":"22","author":"Mitsogiannis","year":"2022","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.yexmp.2024.104904_bb0655","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8844030","article-title":"Dendrimers: a new race of pharmaceutical nanocarriers","volume":"2021","author":"Mittal","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2016.08.018","article-title":"Predicting time from metastasis to overall survival in castration-resistant prostate cancer: results from SEARCH","volume":"15","author":"Moreira","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"issue":"4s","key":"10.1016\/j.yexmp.2024.104904_bb0665","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol. Clin. North Am."},{"issue":"68","key":"10.1016\/j.yexmp.2024.104904_bb0670","doi-asserted-by":"crossref","first-page":"41560","DOI":"10.1039\/D0RA08617G","article-title":"Photodynamic diagnosis and photodynamic therapy of colorectal cancer in vitro and in vivo","volume":"10","author":"Nompumelelo Simelane","year":"2020","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104904_bb0675","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/tde-2017-0060","article-title":"Delivering natural products and biotherapeutics to improve drug efficacy","volume":"8","author":"Obeid","year":"2017","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10837450.2017.1312441","article-title":"A review of recent developments on micro\/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer","volume":"23","author":"Oliveira","year":"2018","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0685","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdx688","article-title":"Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer","volume":"29","author":"Overman","year":"2018","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0690","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/bjs.5679","article-title":"The Swedish rectal cancer registry","volume":"94","author":"P\u00e5hlman","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.yexmp.2024.104904_bb0695","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/9781119769897.ch7","article-title":"Safety and toxicity issues of polymeric nanoparticles","author":"Patel","year":"2021","journal-title":"Nanotechnol. Med."},{"key":"10.1016\/j.yexmp.2024.104904_bb0700","first-page":"8","article-title":"Biomaterial-mediated internal radioisotope therapy","author":"Pei","year":"2021","journal-title":"Mater. Horiz."},{"issue":"23","key":"10.1016\/j.yexmp.2024.104904_bb0705","article-title":"Nanomaterials for healthcare biosensing applications","volume":"vol. 19","author":"Pirzada","year":"2019","journal-title":"Sensors (Basel, Switzerl.)"},{"key":"10.1016\/j.yexmp.2024.104904_bb0710","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-72041-8_19","article-title":"Using of quantum dots in biology and medicine","volume":"1048","author":"Pleskova","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0715","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.seminoncol.2007.03.005","article-title":"Surgical management of rectal cancer","volume":"34","author":"Rajput","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.127144","article-title":"PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization","volume":"627","author":"Raspantini","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"37","key":"10.1016\/j.yexmp.2024.104904_bb0725","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/37\/375101","article-title":"Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle","volume":"20","author":"Roa","year":"2009","journal-title":"Nanotechnology"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0730","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1435227","article-title":"Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer","volume":"7","author":"Roxburgh","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2024.104904_bb0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2017.03.009","article-title":"Cellular determinants and microenvironmental regulation of prostate cancer metastasis","volume":"44","author":"Rycaj","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexmp.2024.104904_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.micromeso.2020.110774","article-title":"Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration","volume":"312","author":"S\u00e1bio","year":"2021","journal-title":"Microporous Mesoporous Mater."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0745","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00432-012-1308-x","article-title":"Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy","volume":"139","author":"Saigusa","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0750","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-044X-1-2","article-title":"Application of magnetic techniques in the field of drug discovery and biomedicine","volume":"1","author":"Saiyed","year":"2003","journal-title":"Biomagn. Res. Technol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0755","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/acsabm.2c00975","article-title":"D2B-functionalized gold nanoparticles: promising vehicles for targeted drug delivery to prostate cancer","volume":"6","author":"Sarkis","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"7","key":"10.1016\/j.yexmp.2024.104904_bb0760","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cas.12419","article-title":"Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer","volume":"105","author":"Sasaki","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexmp.2024.104904_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-95693-0_1","article-title":"Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies","volume":"1095","author":"Schatten","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139440","article-title":"Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model","volume":"10","author":"Scher","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2024.104904_bb0775","article-title":"Review of clinical applications of radiation-enhancing nanoparticles","volume":"28","author":"Scher","year":"2020","journal-title":"Biotechnol. Rep. (Amst.)"},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102205","article-title":"Quantifying radiosensitization of PSMA-targeted gold nanoparticles on prostate cancer cells at megavoltage radiation energies by Monte Carlo simulation and local effect model","volume":"14","author":"Schmidt","year":"2022","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.yexmp.2024.104904_bb0785","first-page":"27","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","author":"Sekhoacha","year":"2022","journal-title":"Molecules (Basel, Switzerl.)"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0790","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1039\/C3NR05961H","article-title":"Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity","volume":"6","author":"Sethi","year":"2014","journal-title":"Nanoscale"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb0795","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/02652048.2022.2135785","article-title":"Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting","volume":"39","author":"Sharma","year":"2022","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0800","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12951-022-01650-z","article-title":"Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications","volume":"20","author":"Sharma","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus Ipilimumab for metastatic castration-resistant prostatec: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0810","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2024.104904_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111035","article-title":"LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs docetaxel and quercetin for prostate cancer","volume":"114","author":"Shitole","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.yexmp.2024.104904_bb0820","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2017.05.024","article-title":"Cytokines in immunogenic cell death: applications for cancer immunotherapy","volume":"97","author":"Showalter","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0825","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2008.03.009","article-title":"A novel mathematical model quantifying drug release from lipid implants","volume":"128","author":"Siepmann","year":"2008","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0830","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s12011-020-02255-z","article-title":"Silver nanoparticles synthesized using Carica papaya leaf extract (AgNPs-PLE) causes cell cycle arrest and apoptosis in human prostate (DU145) Cancer cells","volume":"199","author":"Singh","year":"2021","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.yexmp.2024.104904_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114505","article-title":"Image-guided intratumoral immunotherapy: developing a clinically practical technology","volume":"189","author":"Som","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"32","key":"10.1016\/j.yexmp.2024.104904_bb0840","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.yexmp.2024.104904_bb0845","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104904_bb0850","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2024.104904_bb0855","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40824-020-00190-7","article-title":"Recent advances in polymeric drug delivery systems","volume":"24","author":"Sung","year":"2020","journal-title":"Biomater. Res."},{"key":"10.1016\/j.yexmp.2024.104904_bb0860","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2147\/IJN.S189688","article-title":"Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer","volume":"14","author":"Suo","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"15","key":"10.1016\/j.yexmp.2024.104904_bb0865","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications--reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0870","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced prostate cancer: treatment advances and future directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer."},{"key":"10.1016\/j.yexmp.2024.104904_bb0875","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.2147\/IJN.S282107","article-title":"Aptamer-functionalized dendrimer delivery of plasmid-encoding lncRNA MEG3 enhances gene therapy in castration-resistant prostate cancer","volume":"15","author":"Tai","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0880","first-page":"263","article-title":"Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis","volume":"31","author":"Takeda","year":"2011","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8080253","article-title":"Curcumin nanoparticles and their cytotoxicity in docetaxel-resistant castration-resistant prostate cancer cells","volume":"8","author":"Tanaudommongkon","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexmp.2024.104904_bb0890","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semcancer.2021.11.001","article-title":"Understanding and targeting prostate cancer cell heterogeneity and plasticity","volume":"82","author":"Tang","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0895","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00018-023-04694-y","article-title":"Nanoceria: an innovative strategy for cancer treatment","volume":"80","author":"Tang","year":"2023","journal-title":"Cell. Mol. Life Sci.: CMLS."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104904_bb0900","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.apsb.2018.05.011","article-title":"Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy","volume":"8","author":"Tang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0905","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1872210511666171101120157","article-title":"An overview on applications of gold nanoparticle for early diagnosis and targeted drug delivery to prostate cancer","volume":"12","author":"Thambiraj","year":"2018","journal-title":"Recent Pat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104904_bb0910","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1042\/BST20210343","article-title":"Development of next generation nanomedicine-based approaches for the treatment of cancer: we\u2019ve barely scratched the surface","volume":"49","author":"Tracey","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.yexmp.2024.104904_bb0915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphotobiol.2017.04.014","article-title":"Biological effects and medical applications of infrared radiation","volume":"170","author":"Tsai","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104904_bb0920","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4251\/wjgo.v13.i2.119","article-title":"Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure","volume":"13","author":"Tuta","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104904_bb0925","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030601","article-title":"Molecular biomarkers in the clinical management of prostate cancer","volume":"8","author":"Udager","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104904_bb0930","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s12094-019-02274-w","article-title":"Age, Gleason score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of the Uroncor group (Uro-oncological tumors) of the Spanish Society of Radiation Oncology (SEOR)","volume":"22","author":"Valero","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"24","key":"10.1016\/j.yexmp.2024.104904_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246209","article-title":"Prostate-specific membrane antigen targeted pet\/CT imaging in patients with colon, gastric and pancreatic cancer","volume":"14","author":"Vuijk","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2024.104904_bb0940","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actbio.2019.05.044","article-title":"Recent advances in polymer-based drug delivery systems for local anesthetics","volume":"96","author":"Wang","year":"2019","journal-title":"Acta Biomater."},{"issue":"28","key":"10.1016\/j.yexmp.2024.104904_bb0945","article-title":"Dual-pronged attack: pH-driven membrane-anchored NIR dual-type Nano-photosensitizer excites immunogenic Pyroptosis and sequester immune checkpoint for enhanced prostate Cancer photo-immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.yexmp.2024.104904_bb0950","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2147\/IJN.S239751","article-title":"Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0955","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/s41598-017-06142-x","article-title":"Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0960","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","article-title":"Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"36","key":"10.1016\/j.yexmp.2024.104904_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001883","article-title":"Role of artificial intelligence and machine learning in nanosafety","volume":"16","author":"Winkler","year":"2020","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb0970","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/cr5004634","article-title":"Mechanisms of drug release in nanotherapeutic delivery systems","volume":"115","author":"Wong","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yexmp.2024.104904_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120654","article-title":"Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment","volume":"269","author":"Wu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexmp.2024.104904_bb0980","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1038\/srep09445","article-title":"Multivalent conjugation of antibody to dendrimers for the enhanced capture and regulation on colon cancer cells","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb0985","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13287-019-1288-8","article-title":"Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy","volume":"10","author":"Xu","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.yexmp.2024.104904_bb0990","article-title":"Engineering radiosensitizer-based metal-phenolic networks potentiate STING pathway activation for advanced radiotherapy","volume":"34","author":"Yan","year":"2022","journal-title":"Adv. Mater. (Deerfield Beach, Fla)."},{"key":"10.1016\/j.yexmp.2024.104904_bb0995","article-title":"The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.yexmp.2024.104904_bb1000","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpha.2023.06.001","article-title":"Applications and safety of gold nanoparticles as therapeutic devices in clinical trials","volume":"13","author":"Yao","year":"2023","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568009033333754","article-title":"Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation","volume":"3","author":"Yusuf","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb1010","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-017-01968-5","article-title":"Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2024.104904_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106199","article-title":"Co-delivery of docetaxel and resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer","volume":"174","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Feder. Pharm. Sci."},{"key":"10.1016\/j.yexmp.2024.104904_bb1020","article-title":"Nanodrugs systems for therapy and diagnosis of esophageal cancer","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb1025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/10717544.2022.2050845","article-title":"Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb1030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12951-020-00698-z","article-title":"Synthesis of graphene quantum dots and their applications in drug delivery","volume":"18","author":"Zhao","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.yexmp.2024.104904_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113714","article-title":"Current progress of nanomedicine for prostate cancer diagnosis and treatment","volume":"155","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2024.104904_bb1040","article-title":"Chemotherapy-enabled colorectal cancer immunotherapy of self-delivery nano-PROTACs by inhibiting tumor glycolysis and avoiding adaptive immune resistance","author":"Zhao","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104904_bb1045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10717544.2021.2023698","article-title":"GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer","volume":"29","author":"Zhao","year":"2022","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104904_bb1050","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.18632\/oncotarget.14072","article-title":"Targeted delivery of CRISPR\/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome","volume":"8","author":"Zhen","year":"2017","journal-title":"Oncotarget"},{"issue":"41","key":"10.1016\/j.yexmp.2024.104904_bb1055","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1002\/adma.201000369","article-title":"Self-assembly of hyperbranched polymers and its biomedical applications","volume":"22","author":"Zhou","year":"2010","journal-title":"Adv. Mater."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480024000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480024000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:47:59Z","timestamp":1718412479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480024000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":211,"alternative-id":["S0014480024000236"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2024.104904","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies \u2013 Spotlight on prostate and colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2024.104904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104904"}}